Published: 03/10/2023
On behalf of the Fogarty International Center at the U.S. National Institutes of Health (NIH), the following funding opportunities, notices and announcements may be of interest to those working in the field of global health research.
Special Announcements
Just announced! Climate Change and Health Research Center Grants
NIH is building its climate change and health research portfolio with funding opportunities to develop Climate Change and Health Research Centers. Fogarty is a partner on this opportunity.
- Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)
- Application Receipt Date(s): May 1, 2023; November 7, 2023
Supplemental funds available to enhance diversity
Recipients of Fogarty research grants in U.S. institutions can apply for supplementary support to enhance the diversity of the U.S. global health research workforce. These supplements provide support to current grantees for students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research.
- Research Supplements to Promote Diversity in Health-Related Research (PA-21-071)
- Questions? Contact FIC’s scientific or grants contacts
- Application deadline: May 8, 2023
Your input needed: Cancer clinical trials in low- and middle-income countries
The National Cancer Institute (NCI) is soliciting input about how to increase high-quality cancer therapeutic clinical trials in low- and middle-income countries (LMICs) as well as the key research priorities for such clinical trials.
- Request for Information (RFI): Cancer Therapeutic Clinical Trials in Low- and Middle-Income Countries (NOT-CA-23-015)
- Response date: March 10, 2023
Upcoming Deadlines for Fogarty Funding Opportunities
- International Research Scientist Development Award (IRSDA)
Application deadline: March 8, 2023
Upcoming deadlines for funding opportunities in which Fogarty is a funding partner
- Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments:
- R01 (Clinical Trial Optional) (PAR-23-042)
- R61/R33 (Clinical Trial Required) (PAR-23-043)
- Application assistance webinar video, presentation, and transcript
- Application deadline: March 9, 2023
Funding Opportunities
NIH and FDA funding opportunities focusing on global health and foreign collaboration:
- Cooperative Agreement to Support the Food and Agriculture Organization (FAO) (U01) Clinical Trials Not Allowed (RFA-FD-23-020)
Application receipt date: March 7, 2023 - Site Selection in Oncology Clinical Trials: Considerations for Selecting Sites in Limited Geographic Regions or Areas of Political Unrest, Limiting Inspection Capabilities (U13) Clinical Trial not allowed. (RFA-FD-23-007)
Application receipt date: March 7, 2023 - International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed) (RFA-AI-22-067)
Application receipt date: May 5, 2023 - Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Application receipt date: May 7, 2023
NIH funding opportunities for which foreign organizations and/or foreign components of U.S. organizations may apply:
- Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed)
Application receipt date(s): October 10, 2023 - Genomic Community Resources (U24 Clinical Trial Not Allowed)
Application receipt date(s): Multiple dates, see announcement. - Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
Application receipt date(s): Multiple dates, see announcement. - Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
Application receipt date(s): Multiple dates, see announcement.
NIH funding opportunities for which foreign components may apply:
- Advancing Integrated Models (AIM) of Care to Improve Pregnancy Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Optional)
Application receipt date(s): May 1, 2023 - Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)
Application receipt date(s): May 1, 2023 - Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Required)
Application receipt date(s): May 1, 2023 - Research Network to Promote Multidisciplinary Mechanistic and Translational Studies of Sickle Cell Disease Pain (U24, Clinical Trial Optional)
Application receipt date(s): October 1, 2023 - Limited Competition: NIDDK Program Projects (P01 Clinical Trial Optional)
Application receipt date(s): Multiple dates, see announcement. - NIMH Short Courses for Mental Health Related Research (R25 -Independent Clinical Trial Not Allowed)
Application receipt date(s): Multiple dates, see announcement. - Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed)
Application receipt date(s): Multiple dates, see announcement.